                         SEQUENCE LISTING

<110>  Cytogel Pharma, LLC
       Maione, Theodore
       Hamsher, James
       Maglaris, Constantine Basil
 
<120>  Polymer Agonists of Mu Opioid Receptors

<130>  CYT.110XC1

<150>  62/588,013
<151>  2017-11-17

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  polymer agonist of Mu opioid receptors


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be any amino acid; a residue other than lysine, 
       glutamate, aspartate, ornithine, or proline; or a residue as 
       disclosed in the specification

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa can be any amino acid or a residue other than an aromatic 
       amino acid

<400>  1

Tyr Xaa Xaa Phe 
1               


<210>  2
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  polymer agonist of Mu opioid receptors


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be any amino acid; a residue other than lysine, 
       glutamate, aspartate, ornithine, or proline; or a residue as 
       disclosed in the specification

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa can be any amino acid or a residue other than an aromatic 
       amino acid

<400>  2

Tyr Xaa Xaa Phe Glu 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  polymer agonist of Mu opioid receptors


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be any amino acid; a residue other than lysine, 
       glutamate, aspartate, ornithine, or proline; or a residue as 
       disclosed in the specification

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa can be any amino acid or a residue other than an aromatic 
       amino acid

<400>  3

Tyr Xaa Xaa Phe Asp 
1               5   


<210>  4
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  polymer agonist of Mu opioid receptors


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be any amino acid; a residue other than lysine, 
       glutamate, aspartate, ornithine, or proline; or a residue as 
       disclosed in the specification

<220>
<221>  MISC_FEATURE
<222>  (2)..(5)
<223>  Residues 2 and 5 form a cyclic structure

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa can be any amino acid or a residue other than an aromatic 
       amino acid

<400>  4

Tyr Xaa Xaa Phe Glu 
1               5   


<210>  5
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  polymer agonist of Mu opioid receptors


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa can be any amino acid; a residue other than lysine, 
       glutamate, aspartate, ornithine, or proline; or a residue as 
       disclosed in the specification

<220>
<221>  MISC_FEATURE
<222>  (2)..(5)
<223>  Residues 2 and 5 form a cyclic structure

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa can be any amino acid or a residue other than an aromatic 
       amino acid

<400>  5

Tyr Xaa Xaa Phe Asp 
1               5   


